Submit approval filings in the United States and Europe
Not delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 27 Jan 2021
- Due
- 31 Dec 2021
- Checked
- 25 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“If trial concludes at interim, filings for approval in the United States and in Europe targeted by year end 2021”
What we found
Evidence strength A What the grades mean
The company did not submit the regulatory filings by the year-end 2021 deadline, with later filings indicating the BLA submission was still pending or delayed into 2022.
-
A Erytech Pharma S.A. 6-K filed 2022-04-25
“regarding a potential BLA submission for GRASPA® in hypersensititve ALL, now targeted in the third quarter of 2022” ✓ confirmed on the page
-
A Erytech Pharma S.A. 6-K filed 2022-03-15
“BLA almost ready to submit pending FDA’s acceptance to file application” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory other
- Indicative materiality
- Medium rules
- Action
- Submit
- Deliverable
- Approval filings in US and Europe
- In the company’s control
- Medium
- Specificity
- Medium
- Conditional
- Yes: If trial concludes at interim
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
- Third check on a negative finding: agreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Erytech Pharma S.A.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C624422-022519 · Corrections policy